User login
A supplement to Ob. Gyn. News.
Supported by a restricted educational grant from 3M Pharmaceuticals.
Highlights of presentations that took place at a continuing medical education conference held April 5-6, 2003, Washington, DC.
To view the supplement, click the image above.
Contents/Faculty Disclosure
Introduction
Jack D. Sobel, MD
Professor, Chief
Division of Infectious Disease
Wayne State University School of Medicine
Harper Hospital
Detroit, MI
Clinical Grants: 3M Pharmaceuticals, Pfizer, and Ortho-McNeil. Discusses the investigational use of fluconazole and 17.4% topical flucytosine cream for treating Candida glabrata, and 10% hydrocortisone for treating erosive lichen planus.
Phillip G. Stubblefield, MD
Professor and Chairman, Obstetrics and Gynecology
Boston University School of Medicine
Director, Obstetrics and Gynecology
Boston Medical Center
Boston, MA
Nothing to disclose.
Jonathan M. Zenilman, MD
Professor, Infectious Diseases Division
Johns Hopkins School of Medicine
Baltimore, MD
Clinical Grants/Research: Osmetech PLC; Consultant: Merck and Company; Speaker's Bureau: GlaxoSmithKline, Pfizer, Inc.
Normal Vaginal Flora
Jeanne M. Marrazzo, MD, MPH
Assistant Professor, Department of Medicine
Division of Allergy and Infectious Diseases
University of Washington, Harborview Medical Center
Seattle, WA
Discusses the use of intravaginal Lactobacillus crispatus capsules for the treatment of bacterial vaginosis.
Diagnosis and Treatment of Routine and Resistant Trichomoniasis
Anne M. Rompalo, MD, ScM
Associate Professor, Infectious Diseases Division
Johns Hopkins School of Medicine
Baltimore, MD
Clinical Grants/Research: GlaxoSmithKline; Speaker's Bureau: GlaxoSmithKline, Pfizer, Inc.
New Findings in Routine and Recurrent Vulvovaginal Candidiasis Treatment
Jack D. Sobel, MD
Overview of Bacterial Vaginosis and Its Role in Upper Genital Tract Infection
David A. Eschenbach, MD
Professor and Director, Women's Health
Chair, Department of Obstetrics and Gynecology
University of Washington
Seattle, WA
Consultant: 3M Pharmaceuticals.
Noninfectious Vulvovaginal Symptoms as Manifestations of Systemic Diseases
Jack D. Sobel, MD
Copyright © 2003 by International Medical News Group
A supplement to Ob. Gyn. News.
Supported by a restricted educational grant from 3M Pharmaceuticals.
Highlights of presentations that took place at a continuing medical education conference held April 5-6, 2003, Washington, DC.
To view the supplement, click the image above.
Contents/Faculty Disclosure
Introduction
Jack D. Sobel, MD
Professor, Chief
Division of Infectious Disease
Wayne State University School of Medicine
Harper Hospital
Detroit, MI
Clinical Grants: 3M Pharmaceuticals, Pfizer, and Ortho-McNeil. Discusses the investigational use of fluconazole and 17.4% topical flucytosine cream for treating Candida glabrata, and 10% hydrocortisone for treating erosive lichen planus.
Phillip G. Stubblefield, MD
Professor and Chairman, Obstetrics and Gynecology
Boston University School of Medicine
Director, Obstetrics and Gynecology
Boston Medical Center
Boston, MA
Nothing to disclose.
Jonathan M. Zenilman, MD
Professor, Infectious Diseases Division
Johns Hopkins School of Medicine
Baltimore, MD
Clinical Grants/Research: Osmetech PLC; Consultant: Merck and Company; Speaker's Bureau: GlaxoSmithKline, Pfizer, Inc.
Normal Vaginal Flora
Jeanne M. Marrazzo, MD, MPH
Assistant Professor, Department of Medicine
Division of Allergy and Infectious Diseases
University of Washington, Harborview Medical Center
Seattle, WA
Discusses the use of intravaginal Lactobacillus crispatus capsules for the treatment of bacterial vaginosis.
Diagnosis and Treatment of Routine and Resistant Trichomoniasis
Anne M. Rompalo, MD, ScM
Associate Professor, Infectious Diseases Division
Johns Hopkins School of Medicine
Baltimore, MD
Clinical Grants/Research: GlaxoSmithKline; Speaker's Bureau: GlaxoSmithKline, Pfizer, Inc.
New Findings in Routine and Recurrent Vulvovaginal Candidiasis Treatment
Jack D. Sobel, MD
Overview of Bacterial Vaginosis and Its Role in Upper Genital Tract Infection
David A. Eschenbach, MD
Professor and Director, Women's Health
Chair, Department of Obstetrics and Gynecology
University of Washington
Seattle, WA
Consultant: 3M Pharmaceuticals.
Noninfectious Vulvovaginal Symptoms as Manifestations of Systemic Diseases
Jack D. Sobel, MD
Copyright © 2003 by International Medical News Group
A supplement to Ob. Gyn. News.
Supported by a restricted educational grant from 3M Pharmaceuticals.
Highlights of presentations that took place at a continuing medical education conference held April 5-6, 2003, Washington, DC.
To view the supplement, click the image above.
Contents/Faculty Disclosure
Introduction
Jack D. Sobel, MD
Professor, Chief
Division of Infectious Disease
Wayne State University School of Medicine
Harper Hospital
Detroit, MI
Clinical Grants: 3M Pharmaceuticals, Pfizer, and Ortho-McNeil. Discusses the investigational use of fluconazole and 17.4% topical flucytosine cream for treating Candida glabrata, and 10% hydrocortisone for treating erosive lichen planus.
Phillip G. Stubblefield, MD
Professor and Chairman, Obstetrics and Gynecology
Boston University School of Medicine
Director, Obstetrics and Gynecology
Boston Medical Center
Boston, MA
Nothing to disclose.
Jonathan M. Zenilman, MD
Professor, Infectious Diseases Division
Johns Hopkins School of Medicine
Baltimore, MD
Clinical Grants/Research: Osmetech PLC; Consultant: Merck and Company; Speaker's Bureau: GlaxoSmithKline, Pfizer, Inc.
Normal Vaginal Flora
Jeanne M. Marrazzo, MD, MPH
Assistant Professor, Department of Medicine
Division of Allergy and Infectious Diseases
University of Washington, Harborview Medical Center
Seattle, WA
Discusses the use of intravaginal Lactobacillus crispatus capsules for the treatment of bacterial vaginosis.
Diagnosis and Treatment of Routine and Resistant Trichomoniasis
Anne M. Rompalo, MD, ScM
Associate Professor, Infectious Diseases Division
Johns Hopkins School of Medicine
Baltimore, MD
Clinical Grants/Research: GlaxoSmithKline; Speaker's Bureau: GlaxoSmithKline, Pfizer, Inc.
New Findings in Routine and Recurrent Vulvovaginal Candidiasis Treatment
Jack D. Sobel, MD
Overview of Bacterial Vaginosis and Its Role in Upper Genital Tract Infection
David A. Eschenbach, MD
Professor and Director, Women's Health
Chair, Department of Obstetrics and Gynecology
University of Washington
Seattle, WA
Consultant: 3M Pharmaceuticals.
Noninfectious Vulvovaginal Symptoms as Manifestations of Systemic Diseases
Jack D. Sobel, MD
Copyright © 2003 by International Medical News Group
